Overexpression of the CD155 gene in human colorectal carcinoma

Citation
D. Masson et al., Overexpression of the CD155 gene in human colorectal carcinoma, GUT, 49(2), 2001, pp. 236-240
Citations number
29
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
GUT
ISSN journal
00175749 → ACNP
Volume
49
Issue
2
Year of publication
2001
Pages
236 - 240
Database
ISI
SICI code
0017-5749(200108)49:2<236:OOTCGI>2.0.ZU;2-X
Abstract
Background and aims - The Tage4 gene (tumour associated glycoprotein E4) is overexpressed in rat colon tumours and Min mouse intestinal adenomas. The rat Tage4 protein has approximately 40% identity with human CD155, a member of the immunoglobulin superfamily coding for a transmembrane protein capab le of serving as an entry receptor for poliovirus, porcine pseudorabies vir us, and bovine herpesvirus 1. Analysis of the rat Tage4 gene has revealed s tructural and functional similarities with the human CD155 gene. We therefo re investigated expression of the CD155 gene in human colorectal carcinomas . Methods - Overall CD155 expression was assessed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical a nalysis using tissue specimens from patients with colorectal adenomas and a denocarcinomas. We also used a qualitative RT-PCR assay to determine relati ve expression of different splicing variants in each sample. Results - mRNA levels of CD155 were increased in six of six colorectal canc er tissues compared with the tumour free colon mucosa. Immunohistochemical analysis revealed an increased level of CD155 protein in 12 of 12 samples. The qualitative RT-PCR assay revealed that relative expression of the diffe rent CD155 variant transcripts was similar in the different normal and canc er samples tested, indicating that this overexpression is not associated wi th a particular mRNA variant generated by alternative splicing of the CD155 gene. Conclusion - We have shown for the first time that the CD155 gene is overex pressed in colorectal carcinoma and that this overexpression begins at an e arly stage in tumorigenesis and continues to late stages.